New drug trial targets root of heart and weight problems in black community
NCT ID NCT06320951
Summary
This study is testing if a drug called vericiguat can improve heart and metabolic health in Black adults with obesity and insulin resistance. Researchers will enroll 200 participants to take either the drug or a placebo pill daily for 12 weeks. The main goals are to see if the drug helps the body use insulin better and increases the amount of energy the body burns at rest.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.